Previous 10 | Next 10 |
MISSION VIEJO, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND) , a predictive analytics company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, today announced that the U.S. General Services Administ...
Gainers: Helios and Matheson Analytics (NASDAQ: HMNY ) +49% . Cool Holdings (NASDAQ: AWSM ) +20% . Fortress Biotech (NASDAQ: FBIO ) +19% . Azure Power Global (NYSE: AZRE ) +18% . MYnd Analytics (NASDAQ: MYND ) +18% . Versum Materials (NYSE: VSM ) +16% . Reebonz Holding ( RBZ ) ...
MYnd Analytics (NASDAQ: MYND ) announces entering a definitive stock-for-stock merger agreement with Emmaus Life Sciences. More news on: MYnd Analytics, Inc., Healthcare stocks news, Read more ...
Emmaus’ commercial lead product Endari™ (L-glutamine oral powder) is FDA approved to reduce the acute complications of sickle cell disease Endari addresses a $3 billion worldwide market MISSION VIEJO, Calif. and TORRANCE, Calif., Jan. 07, 2019 (GLOBE NE...
MISSION VIEJO, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND) , a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that the Company’s Psychiatric...
Gainers: Red Hat (NYSE: RHT ) +45% . Diana Containerships (NASDAQ: DCIX ) +24% CASI Pharmaceuticals (NASDAQ: CASI ) +21% . Evogene (NYSE: EVGN ) +19% Cooper Tire & Rubber Company (NYSE: CTB ) +18% . LM Funding America (NASDAQ: LMFA ) +17% . Stoneridge (NYSE: SRI ) +...
MISSION VIEJO, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND) , a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that its wholly owned subsidiary, Ar...
MISSION VIEJO, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND) , a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that its wholly owned subsidiary, Ar...
MISSION VIEJO, Calif., Sept. 11, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND ) , a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that its wholly owned subsidiary, ...
Highlights 4.7 to 1 cost offset when PEER is Applied Builds on earlier publications confirming clinical utility of PEER in Targeting Treatments MISSION VIEJO, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND) , a market leader in improving the delivery...
News, Short Squeeze, Breakout and More Instantly...
Mynd Life Sciences Inc Com Company Name:
MYND Stock Symbol:
NASDAQ Market:
Mynd Life Sciences Inc Com Website:
Mynd Announces Fiscal Year 2023 Results PR Newswire Delivers Revenue of $413.6 Million and Successfully Completes Transformational Merger Transaction SEATTLE , March 27, 2024 /PRNewswire/ -- Mynd.ai, Inc. (the "Company" or "...
Promethean wins three Tech & Learning Awards of Excellence for 2023 Promethean wins three Tech & Learning Awards of Excellence for 2023 PR Newswire The company was recognized for its ActivPanel LX display, OPS-A computing module, and Explain Everything Advanced les...
Mynd.ai to Ring NYSE First Trade Bell on February 5th PR Newswire SEATTLE , Feb. 2, 2024 /PRNewswire/ -- Mynd.ai, Inc. ("Mynd" or the "Company") (NYSE American: MYND), today announced that Vin Riera , CEO, alongside members of Mynd's executive management team...